1. Mutagenicity and preclinical safety assessment of the aqueous extract of Clinacanthus nutans leaves.
- Author
-
Farsi E, Esmailli K, Shafaei A, Moradi Khaniabadi P, Al Hindi B, Khadeer Ahamed MB, Sandai D, Abdul Sattar M, Ismail Z, Abdul Majid AM, and Abdul Majid AS
- Subjects
- Animals, Drug Evaluation, Preclinical, Female, Lethal Dose 50, Male, Mutagenicity Tests, No-Observed-Adverse-Effect Level, Rats, Sprague-Dawley, Salmonella typhimurium genetics, Toxicity Tests, Acute, Toxicity Tests, Chronic, Acanthaceae chemistry, Plant Extracts toxicity, Plant Leaves chemistry, Salmonella typhimurium drug effects
- Abstract
Context: Clinacanthus nutans (CN) is used traditionally for treating various illnesses. Robust safety data to support its use is lacking., Objective: To evaluate the adverse effects of aqueous extract of CN leaves (AECNL)., Materials and Methods: The oral toxicity of the AECNL was tested following Organisation for Economic Co-operation and Development (OECD) guidelines. Mutagenicity (Ames test) of AECNL was evaluated using TA98 and TA100 Salmonella typhimurium strains., Results: No mortality or morbidity was found in the animals upon single and repeated dose administration. However, significant body weight loss was observed at 2000 mg/kg during sub-chronic (90 d) exposure. In addition, increased eosinophil at 500 mg/kg and decreased serum alkaline phosphatase levels at 2000 mg/kg were observed in male rats. Variations in glucose and lipid profiles in treated groups were also observed compared to control. Ames test revealed no evidence of mutagenic or carcinogenic effects at 500 μg/well of AECNL., Conclusion: The median lethal dose (LD50) of the AECNL is >5000 mg/kg and the no-observed-adverse-effect level is identified to be greater than 2000 mg/kg/day in 90-d study.
- Published
- 2016
- Full Text
- View/download PDF